Market volume of biopharmaceuticals in Germany: € 12.7 bln.
Market volume of skin care products in Germany: € 4.11 bln.
77.8 % of all non-surgical beauty procedures are botulinum toxin and hyaluronic acid treatments
— A specialised portfolio focused on chronic diseases
As a pharmaceutical manufacturer and wholesaler, HAEMATO helps to ensure that every patient benefits from the latest innovative therapies and treatment concepts, even if these are very expensive due to complex development and production processes.
At HAEMATO, the focus is always on the patient. In particular, HAEMATO covers chronic conditions and high-priced therapies with a specialised portfolio. The focus is on the five major therapeutic areas of HIV/AIDS, neurology, oncology, rheumatology and ophthalmology.
Lifestyle & Aesthetics
— A holistic approach to aesthetic needs
In addition to demographic development, medical-technological progress and the population's evolving focus on health, rising household incomes ensure that in the long them there is an increasing demand for products and services in the medical-aesthetic market. Society, which is getting older and staying fit longer, wants to look their perceived age. Also, due to the increased social acceptance of beauty medicine, the beauty market is a growing branch within the health market.
In the field of lifestyle and aesthetics, HAEMATO will continue to develop and market pharmaceutical, medical and medical-technological products for aesthetic surgery and cosmetic dermatology.
The strategy focuses on close cooperation with physicians and patients. The goal is to meet the needs of patients and physicians through scientific knowledge and technological advancement and to achieve our vision of unrestricted well-being for all patients through optimal care.